Serum Histone Succinylation as a Novel Prognostic Biomarker in Hematological Malignancies
Clinical trial NCT07131449 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07131449
- Sponsor
- The First Affiliated Hospital of Xinxiang Medical College
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-09-01
- Primary completion
- 2027-12-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.